Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials

Published:2018-05-29 Issue:9 Volume:20 Page:2131-2139
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Huang Chi-Jung¹,Wang Wei-Ting²,Sung Shih-Hsien²³⁴,Chen Chen-Huan²³⁵,Lip Gregory Y. H.⁶⁷,Cheng Hao-Min¹²³⁵^ORCID,Chiang Chern-En⁴⁸

Affiliation:

1. Center for Evidence-based Medicine, Taipei Veterans General Hospital; Taipei Taiwan

2. Division of Cardiology, Department of Internal Medicine; Taipei Veterans General Hospital; Taipei Taiwan

3. Institute of Public Health and Community Medicine Research Center; National Yang-Ming University; Taipei Taiwan

4. Department of Medicine; National Yang-Ming University; Taipei Taiwan

5. Department of Medical Education; Taipei Veterans General Hospital; Taipei Taiwan

6. Institute for Cardiovascular Sciences; University of Birmingham; Birmingham UK

7. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health; Aalborg University; Aalborg Denmark

8. General Clinical Research Center; Taipei Veterans General Hospital; Taipei Taiwan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13342/fullpdf

Reference49 articles.

1. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000

2. US Centers for Disease Control and Prevention Diabetes statistics; 2014 http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html

3. American Diabetes Association Diabetes statistics http://www.diabetes.org

4. UK prospective diabetes study (UKPDS) group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);Lancet,1998

5. UK prospective diabetes study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging In The Face of Diabetes: Severe Hypoglycemia in Older Adults;Canadian Diabetes & Endocrinology Today;2024-08-30

2. A proposed computational workflow for bioinformatics-based drug repurposing: A case study of Canagliflozin;2024 International Conference on Machine Intelligence and Smart Innovation (ICMISI);2024-05-12

3. Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents;Diabetes, Obesity and Metabolism;2024-02-20

4. Hypoglycemia, insulin resistance, and cardiovascular disease: A possible link;Metabolic Syndrome;2024

5. Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials;Cardiovascular Diabetology;2023-03-19